The debate of whether or not cannabis has medicinal value is over.
The new debate is “How much medicinal value does this plant possess?”
The short answer is A LOT. However, because of Federal prohibition and THC’s schedule 1 drug status, it has been nearly impossible for doctors and scientists to conduct comprehensive studies to explore marijuana’s full medical potential. Fortunately, doctors and scientists on the West Coast have been researching medical marijuana since the mid 1990’s and researchers in Israel have studied cannabis since the 1970’s. Hundreds of reputable studies have concluded that the cannabinoids, terpenoids, and flavonoids found in cannabis offer superior treatment options to a wide range of diseases and other medical conditions. In addition to powerful medicinal value, none of the compounds have shown toxicity when administered in the amounts found naturally occurring in the cannabis plant. Remember, THC is the ONLY psychoactive compound found in the cannabis plant and it is not psychoactive in its natural state. Basically, eating raw marijuana will not produce any high, impairment or addiction. It has to be heated to remove the carboxylic acid molecule to produce psychoactive effects.
The immediate focus of medical marijuana’s medical power is severe epilepsy. It is imperative that we allow access for this condition due to the critical nature of seizures. A severe seizure could kill any of these epileptic children at any time. It is proven that CBD-rich cannabis strains can prevent seizures from occurring.
Other serious conditions that medical marijuana treats, with miraculous results, are multiple sclerosis, cerebral palsy, some cancers, and AIDS. Cannabis’ efficacy at treating these conditions is well documented.
While all of the conditions mentioned above are serious and life-threatening, they affect a small segment of the population. This next one is a big boy…
Medical Marijuana can prevent Alzheimer’s Disease and dementia.
Studies going back as far as the mid-1970’s showed that cannabidiol (CBD) and tetrahydrocannabinolic acid (THCA) act in synergy to create powerful neuroprotective properties. More recent studies show many of the terpenoids and flavonoids are Acetylcholinesterase inhibitors (AChEI). Acetylcholinesterase is an enzyme that stops a nerve after it sends an impulse. Over time this enzyme builds up in our brains and blocks neurons from firing and sending information. This is what causes memory loss with age and leads to Alzheimer’s Disease and dementia.
Cannabinoids fight this brain degeneration in a few different ways. Some cannabinoids are antioxidants that physically remove the acetylcholinesterase build up and clean off the blocked receptors. Other cannabinoids act as neurotransmitters and stimulate the neurons to fire properly.
!!!!!NEW INFO UPDATE 2/2/2106!!!!
New research shows that age-related neurodegenerative conditions are caused by chronic, untreated brain inflammation. Post-mortem brains of Alzheimer’s and dementia victims show elevated levels of inflammatory cytokines IL-1, IL-2, IL-6, and TNF-a. Also, the CB1 and CB2 receptors in the brain were over expressed. We know that there receptors are responsible for fighting the damage of inflammation and preventing excitotoxicity.
CBD and THC are both powerful anti-inflammatory compounds that can easily and safely pass through the brain and heal chronic inflammation. Here’s a study that proves this. The influence of cannabinoids on generic traits of neurodegeneration
Here’s the simple way of saying this. Some cannabinoids found in marijuana clean the bad stuff that causes Alzheimer’s off our brains, then other cannabinoids repair damage and make our brains work like when we were younger.
This may sound contrary to common knowledge because of the ‘spacey stoner’ stereotypes. The short-term memory loss and dopey behavior of potheads is due to strains that have too much THC and not enough CBD. Recreational strains of marijuana may have over 35:1 THC to CBD ratios. If the THC is activated, this kind of strain will get someone very high. The strains for which Halcyon Organics advocates have THC to CBD ratios of 1:22.
Our high CBD strains do not cause high or memory loss. In fact, they promote brain function and increase memory.
Now to the Baby Boomers…
There were nearly 80 million Baby Boomers born between 1946 and 1964. That is nearly 30% of the current U.S. population. They are aging. Doctors estimate that at least 1 out of 3 Baby Boomers will develop Alzheimer’s Disease. As healthcare improves and we live longer, these numbers will increase.
Alzheimer’s Disease will affect all of us at some point. It will affect our parents, our aunts and uncles, our friend’s parents, our parent’s friends, and then eventually, us. Watching a loved suffer from Alzheimer’s Disease is devastating. When someone you have known your entire life stares blankly at you and says, “You look nice. What’s your name?”, it makes your stomach churn. Seeing this disease reduce someone who was once a dynamic, influential member of society to an empty human shell is heartbreaking.
Medical marijuana can help to prevent this. Halcyon Organics will help to prevent this. We have the medication and products to begin safely testing marijuana’s ability to prevent Alzheimer’s Disease. We just need the laws to allow us to study this without fear of going prison.
We could go to prison for researching a plant that is proven to prevent Alzheimer’s Disease.
If you think that doctors and scientists should be working to find a cure or treatment for Alzheimer’s Disease, email and call you local state representative and state senator and tell them to support medical marijuana legislation in Georgia.
Remember, Halcyon Organics can administer Alzheimer’s prevention treatment using non-psychoactive, edible form of medical marijuana. You don’t have to smoke anything and you don’t have to get high to enjoy the medicinal value of the cannabis plant!
By: Daniel Macris, founder and ceo of Halcyon Organics.
© 2015 Halcyon Organics